Total Payments
$374,918
2024 Payments
$85,811
Companies
41
Transactions
1,244
Medicare Patients
2,542
Medicare Billing
$550,883
Payment Breakdown by Category
Other$320,409 (85.5%)
Food & Beverage$22,672 (6.0%)
Travel$17,323 (4.6%)
Consulting$14,088 (3.8%)
Education$426.12 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $308,844 | 225 | 82.4% |
| Food and Beverage | $22,672 | 795 | 6.0% |
| Travel and Lodging | $17,323 | 187 | 4.6% |
| Consulting Fee | $14,088 | 11 | 3.8% |
| Honoraria | $11,565 | 3 | 3.1% |
| Education | $426.12 | 23 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $120,634 | 173 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $117,611 | 290 | $0 (2024) |
| Travere Therapeutics, Inc. | $40,996 | 89 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $40,105 | 145 | $0 (2024) |
| Lilly USA, LLC | $9,859 | 26 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $8,635 | 32 | $0 (2024) |
| Vifor Pharma, Inc. | $6,296 | 33 | $0 (2024) |
| SCPHARMACEUTICALS INC. | $6,050 | 2 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $5,597 | 25 | $0 (2024) |
| ANI Pharmaceuticals, Inc. | $4,353 | 20 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $85,811 | 243 | Bayer Healthcare Pharmaceuticals Inc. ($30,246) |
| 2023 | $66,363 | 215 | Travere Therapeutics, Inc. ($23,528) |
| 2022 | $112,668 | 274 | Bayer HealthCare Pharmaceuticals Inc. ($56,955) |
| 2021 | $50,739 | 166 | Bayer HealthCare Pharmaceuticals Inc. ($28,102) |
| 2020 | $11,380 | 101 | AstraZeneca Pharmaceuticals LP ($5,935) |
| 2019 | $41,205 | 149 | AstraZeneca Pharmaceuticals LP ($30,771) |
| 2018 | $4,191 | 59 | Otsuka America Pharmaceutical, Inc. ($3,311) |
| 2017 | $2,561 | 37 | Mallinckrodt LLC ($1,931) |
All Payment Transactions
1,244 individual payment records from CMS Open Payments — Page 1 of 50
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: NEPHROLOGY | ||||||
| 12/10/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $30.02 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/09/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Honoraria | Cash or cash equivalent | $6,000.00 | General |
| Category: Cardiology | ||||||
| 12/09/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Travel and Lodging | Cash or cash equivalent | $50.48 | General |
| Category: Cardiology | ||||||
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Travel and Lodging | In-kind items and services | $884.45 | General |
| Category: DIABETES | ||||||
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $77.72 | General |
| Category: DIABETES | ||||||
| 12/05/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $29.51 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,575.00 | General |
| Category: Cardio-renal | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $900.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/29/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Travel and Lodging | Cash or cash equivalent | $15.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/29/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Travel and Lodging | Cash or cash equivalent | $5.76 | General |
| Category: IMMUNOLOGY | ||||||
| 11/28/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Travel and Lodging | In-kind items and services | $13.40 | General |
| Category: Cardio-renal | ||||||
| 11/27/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Travel and Lodging | In-kind items and services | $21.44 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/27/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/20/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $25.81 | General |
| Category: NEPHROLOGY | ||||||
| 11/18/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $740.00 | General |
| Category: Diabetes | ||||||
| 11/18/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $25.29 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $23.52 | General |
| Category: NEPHROLOGY | ||||||
| 11/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,850.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/06/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $740.00 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: DIABETES | ||||||
| 11/05/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $25.03 | General |
| Category: NEPHROLOGY | ||||||
| 11/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 685 | 1,245 | $334,602 | $127,727 |
| 2022 | 12 | 637 | 1,169 | $331,800 | $125,886 |
| 2021 | 12 | 605 | 1,080 | $325,635 | $132,607 |
| 2020 | 14 | 615 | 1,396 | $510,701 | $164,663 |
Total Patients
2,542
Total Services
4,890
Medicare Billing
$550,883
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 244 | 529 | $122,728 | $47,632 | 38.8% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 15 | 120 | $75,600 | $27,050 | 35.8% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 14 | 70 | $44,100 | $16,350 | 37.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 161 | 209 | $31,141 | $13,197 | 42.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 65 | 65 | $21,125 | $7,813 | 37.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 67 | 115 | $18,170 | $7,107 | 39.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 34 | 51 | $10,659 | $4,690 | 44.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 21 | 21 | $5,250 | $1,970 | 37.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $2,954 | $1,167 | 39.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 12 | 13 | $1,963 | $666.33 | 33.9% |
| 81003 | Automated urinalysis test | Office | 2023 | 38 | 38 | $912.00 | $83.60 | 9.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 214 | 463 | $107,416 | $42,211 | 39.3% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2022 | 15 | 110 | $69,300 | $25,311 | 36.5% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 14 | 60 | $37,800 | $14,075 | 37.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 157 | 213 | $31,737 | $13,417 | 42.3% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 11 | 44 | $32,340 | $12,028 | 37.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 64 | 64 | $20,800 | $7,417 | 35.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 55 | 84 | $13,272 | $4,593 | 34.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 37 | 55 | $8,305 | $3,169 | 38.2% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 16 | 20 | $4,280 | $1,534 | 35.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 13 | 15 | $3,135 | $1,162 | 37.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 13 | 13 | $2,743 | $908.32 | 33.1% |
| 81003 | Automated urinalysis test | Office | 2022 | 28 | 28 | $672.00 | $62.11 | 9.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 180 | 350 | $75,460 | $33,079 | 43.8% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 19 | 112 | $82,320 | $32,335 | 39.3% |
About Dr. Sheldon Shore, MD
Dr. Sheldon Shore, MD is a Nephrology healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1588647697.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sheldon Shore, MD has received a total of $374,918 in payments from pharmaceutical and medical device companies, with $85,811 received in 2024. These payments were reported across 1,244 transactions from 41 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($308,844).
As a Medicare-enrolled provider, Shore has provided services to 2,542 Medicare beneficiaries, totaling 4,890 services with total Medicare billing of $550,883. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Atlanta, GA
- Active Since 11/22/2005
- Last Updated 03/26/2013
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1588647697
Products in Payments
- Kerendia (Drug) $120,634
- FARXIGA (Drug) $71,635
- LOKELMA (Drug) $45,452
- JYNARQUE (Drug) $39,839
- JARDIANCE (Drug) $18,414
- ACTHAR (Biological) $7,614
- FUROSCIX (Drug) $6,050
- PURIFIED CORTROPHIN GEL (Drug) $4,474
- LUPKYNIS (Drug) $3,134
- Veltassa (Drug) $998.08
- KRYSTEXXA (Biological) $891.30
- BENLYSTA (Biological) $634.78
- RAYALDEE (Drug) $536.01
- Rayaldee (Drug) $459.57
- Parsabiv (Drug) $427.84
- SAMSCA (Drug) $356.30
- Auryxia (Drug) $327.89
- Velphoro (Drug) $304.03
- INJECTAFER (Drug) $290.84
- Parsabiv (Biological) $282.96
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Atlanta
Dr. Christina Klein, Md, MD
Nephrology — Payments: $162,438
Nephrology $162,438
Frederic Rahbari Oskoui, Md, MD
Nephrology — Payments: $91,582
Nephrology $91,582
Dr. Haimanot Wasse, Md, Mph, MD, MPH
Nephrology — Payments: $74,835
Nephrology $74,835
Tarik Lalwani, Md, MD
Nephrology — Payments: $64,361
Nephrology $64,361
Janice Lea, M.d, M.D
Nephrology — Payments: $35,190
Nephrology $35,190
Dr. Elizabeth Nguyen, M.d, M.D
Nephrology — Payments: $33,926
Nephrology $33,926